Tardive Dyskinesia

Deep Brain Stimulation Treatment for Tardive Dyskinesia Successful in 1 Adolescent Patient

February 06, 2019


The patient started treatment with resperidone at age 7 but wasn't diagnosed with tardive dyskinesia until age 17.

Unwise to Use Tardive Dyskinesia as an Umbrella Term

January 16, 2019


More specificity with this group of disorders will help treat them the appropriate way.

Valbenazine Proves Safe and Effective for Tardive Dyskinesia Patients with Mood Disorders

January 11, 2019


The study focused on patients with bipolar or depressive disorder.

Consider Patient and Caregiver Assessments in Tardive Dyskinesia Screenings

January 07, 2019


Patient and caregiver assessments should be considered alongside clinician assessments during tardive dyskinesia screening procedures, as they may differ.

Clozapine Shows Reduction in Tardive Dyskinesia Symptoms

January 07, 2019


It remains unclear whether clozapine treats or suppresses the symptoms of tardive dyskinesia.

FDA Approves Inhaled Parkinson Drug Just Before Government Shutdown

December 27, 2018


The inhaled INBRIJA therapy is indicated to treat 'off' episodes in patients taking carbidopa/levodopa.

Ever-Evolving Treatments & Underpinnings in Tardive Dyskinesia

December 25, 2018


Tardive dyskinesia made strides in 2018 with new and potential treatments as well as unearthed disease underpinnings.

Integrated Care Pathways Improve Older Schizophrenia Patient Care

December 21, 2018


A more multidisciplinary, collaborative care effort for these patients can result in more active monitoring and productive clinical care.

TMS Does Not Vary Between Tardive Syndrome, Healthy Control Patients

December 20, 2018


There were no significant differences among tardive syndrome patients and healthy controls in either resting motor function or active motor function, and both group's symptoms improved with raised intensity.

Mood Disorders Stable with Valbenazine for Tardive Dyskinesia

December 06, 2018


Most of the patients in the study were taking concomitant antidepressants and/or antipsychotics, and mood disorders remained stable during treatment with valbenazine.